GlaxoSmithKline.(Movers & shakers)(appointment of Dan Troy
)(Brief article)
Dan Troy has been appointed senior vice president and general
counsel for UK pharma giant GlaxoSmithKline. Troy was previously chief
counsel for the US Food and Drug Administration, where he was a . . .
Imperial College London.(Movers & shakers)(appointment of
Keith O'Nions )(Brief article)
Keith O'Nions has been appointed director of new security
research institute at Imperial College London. O'Nions will be in
charge of setting-up and developing the new Institute for . . .
PlasticsEurope.(Movers & shakers)
[ILLUSTRATION OMITTED]
Harrie Camps has been appointed director of PlasticsEurope
Nederland. Camps replaces Harry . . .
Generic Pharmaceutical Association.(Movers & shakers)(Brief
article)
The Generic Pharmaceutical Association (GPhA) has appointed Charles
Kinney as executive vice president. Prior to joining the GPhA Kinney was
head of law firm Winston and Strawn's federal . . .
UK National Centre.(Movers & shakers)(appointment of Ian
Kimber at UK National Centre for the Replacement, Refinement and
Reduct
Ian Kimber, a professor of toxicology at the University of
Manchester, has been named as the new chair of the board of the UK
National Centre for the Replacement, Refinement and Reduction of . . .
pSivida.(Movers & shakers)(appointment of Peter Savas and
Paul Hopper )(Brief article)
Peter Savas and Paul Hopper have been appointed to the board of
directors of drug delivery company pSivida. Savas is currently chairman
and ceo of Alseres Pharmaceuticals and Hopper is the founder . . .
Bayer MaterialScience Procurement, NAFTA.(Movers &
shakers)(appointment of Patrick Sion )(Brief article)
Patrick Sion has been appointed head of Bayer MaterialScience
Procurement, NAFTA. Sion, previously head of Bayer MaterialScience
Procurement for the Asia-Pacific region, replaces William Forester, . . .
Eastman.(Movers & shakers)(appointment of Damon Warmack
)(Brief article)
Eastman has appointed Damon Warmack as vice president and general
manager of its performance chemicals and intermediates division. Brad
Lich will take over Warmack's current position as vice . . .
Researchers have used a novel computer modelling technique to
find the structure of one of the tau mutants associated with
Alzhe
Researchers have used a novel computer modelling technique to find
the structure of one of the tau mutants associated with
Alzheimer's, providing a potential target for drug . . .
According to the RCP, some studies have shown ginkgo biloba is
nearly as effective as the cholinesterase inhibitors.(Promising a
According to the RCP, some studies have shown ginkgo biloba is
nearly as effective as the cholinesterase inhibitors, while others
suggest taking vitamin E or the Parkinson's drug selegiline . . .
Melbourne-based Prana reported successful Phase IIa results for
its second generation 8-OH quinolone.(Promising and other
approa
Melbourne-based Prana reported successful Phase IIa results for its
second generation 8-OH quinolone, which blocks the interaction between
amyloid proteins and naturally occurring metal ions in the . . .
The language recall of a small number of patients dramatically
improved after treatment.(Promising and other approaches)
The language recall of a small number of patients dramatically
improved after treatment with Amgen/Wyeth's rheumatoid arthritis
drug Enbrel . . .
Amorfix Life Sciences.(Promising and other approaches)(Brief
article)
Amorfix Life Sciences recently announced a research collaboration
to develop Alzheimer's treatments based on the discovery of
misfolded superoxide dismutase 1 (SOD1) proteins in the brains . . .
Medivation's Dimebon acts in three ways: like a
cholinesterase, a NMDARA, and on a mitochondrial permeability transition
pore, g
Medivation's Dimebon acts in three ways: like a
cholinesterase, a NMDARA, and on a mitochondrial permeability transition
pore, giving it the potential to be neuroprotective. Dimebon gives . . .
Plaques and tangles.(News feature)(Brief article)
The most promising approaches to drug development for
Alzheimer's are focused on either the beta-amyloid plaques or the
tau tangles.
There has been a huge focus on beta-amyloid plaques--stopping . . .
Mindful of progress: good and bad news concerning drugs in
development for Alzheimer's disease suggest a shift in approaches
to
The good news came from TauRx Therapeutics, a Singapore-based
spinout from Aberdeen University. A Phase II study of its drug Rember
(methylthioninium chloride) shows it slows cognitive decline by . . .
All 8000t of steelwork used in the Beijing Olympics'
National Aquatics Center, or Water Cube, was protected by coatings
supplied
All 8000t of steelwork used in the Beijing Olympics' National
Aquatics Center, or Water Cube, was protected by coatings supplied by
Akzo Nobel's International Paint business. Some 1000kg of . . .
Eden Biodesign, the UK provider of biopharmaceutical process
development and cGMP manufacturing services, has signed a marketing
Eden Biodesign, the UK provider of biopharmaceutical process
development and cGMP manufacturing services, has signed a marketing
services agreement with Human Genome Sciences, of Rockville, . . .
German speciality chemicals producer Wacker Chemie has licensed
its proprietary synthesis process to RFS Pharma.(Projects &
Tech
German speciality chemicals producer Wacker Chemie has licensed its
proprietary synthesis process to RFS Pharma, a privately owned biotech
firm based in Tucker, Georgia, US, for the production of . . .
|
|